| Literature DB >> 36065420 |
Tawseef Ayoub Shaikh1, Tabasum Rasool Dar2, Shabir Sofi3.
Abstract
Extended reality (XR) solutions are quietly maturing, and their novel use cases are already being investigated, particularly in the healthcare industry. By 2022, the extended reality market is anticipated to be worth $209 billion. Certain diseases, such as Alzheimer's, Schizophrenia, Stroke rehabilitation stimulating specific areas of the patient's brain, healing brain injuries, surgeon training, realistic 3D visualization, touch-free interfaces, and teaching social skills to children with autism, have shown promising results with XR-assisted treatments. Similar effects have been used in video game therapies like Akili Interactive's EndeavorRx, which has previously been approved by the Food and Drug Administration (FDA) as a treatment regimen for children with attention deficit hyperactivity disorder (ADHD). However, while these improvements have received positive feedback, the field of XR-assisted patient treatment is in its infancy. The growth of XR in the healthcare sphere has the potential to transform the delivery of medical services. Imagine an elderly patient in a remote setting having a consultation with a world-renowned expert without ever having to leave their house. Rather than operating on cadavers in a medical facility, a surgical resident does surgery in a virtual setting at home. On the first try, a nurse uses a vein finder to implant an IV. Through cognitive treatment in a virtual world, a war veteran recovers from post-traumatic stress disorder (PTSD). The paper discusses the potential impact of XR in transforming the healthcare industry, as well as its use cases, challenges, XR tools and techniques for intelligent health care, recent developments of XR in intelligent healthcare services, and the potential benefits and future aspects of XR techniques in the medical domain.Entities:
Keywords: Extended reality; Healthcare informatics; Pattern recognition; Smart health care
Year: 2022 PMID: 36065420 PMCID: PMC9434088 DOI: 10.1007/s13278-022-00888-7
Source DB: PubMed Journal: Soc Netw Anal Min
The extended reality spectrum
Fig. 1Relation between real and virtual worlds in different proportions
Selected XR technology
| Technology name | Type (VR, AR/MR) | Estimated cost, USD | Description |
|---|---|---|---|
| Microsoft Hololens | MR | 3000 | Head-mounted wireless computer system including AR display |
| Google Cardboard | AR | 5–10 | Compact inexpensive cardboard adapter to use smartphones as VR glasses |
| Oculus Rift | VR | 350 | High-fidelity VR headset display; requires a powerful connected computer |
| Oculus Go | VR | 200 | Standalone VR headset; works wirelessly without |
| HTC Vive | VR | 500 | High-fidelity VR headset display; requires a powerful connected computer |
| Magic leap | MR | 2295 | Standalone AR headset; works wirelessly without a computer |
| Google Glass | AR | 1500 | Standalone AR headset; works wirelessly without a computer |
| zSpace | 4000 | AR desktop display monitor; can be viewed by multiple users at once; requires a powerful connected computer | |
| Vuzix Blade | AR | $899 | projects information in both eyes |
| PlayStation VR | VR | $350 | Mostly for gaming with play station. Needs play station and play station camera |
Fig. 2Schematic flowchart of the state-of-the-art works in XR in health care
Fig. 3Outlines medical virtual reality applications by patient involvement, including whether the clinician or patient will be using the virtual reality
Examples of XR anatomy innovations at medical schools
| Description | XR type | School |
|---|---|---|
| Stanford Neurosurgical Simulation and Virtual Reality Center ( | XR Type: VR level of learners: medical students, residents, surgeons Focus: neuroanatomy, neurosurgical procedure training | Stanford |
| HoloAnatomy with Microsoft Hololens (Workman | XR Type: MR level of learners: medical students Focus: general anatomy | Case Western/Cleveland Clinic |
| Immersive Education at CHLA with Oculus Go ( | XR Type: VR level of learners: all incoming residents, optional for medical students Focus: pediatric trauma procedures, pediatric resuscitation training | Children’s Hospital of Los Angeles |
| Virtual Reality Anatomy at USCF with HTC Vive (UCSF VR | XR Type: VR level of learners: first-year medical students Focus: general anatomy | University of California, San Francisco |
| Enduvo VR Teaching and Learning Platform using HTC Vive (The University of Illinois | XR: VR level of learners: medical students, surgeons, faculty Focus: general anatomy | University of Illinois College of Medicine Peoria |
Clinical Summary of XR in neuro-oncologic surgery
| Authors | Surgical purpose | Sample size | Article objective | Brain tumor classification | Analysis software | Clinical outcomes |
|---|---|---|---|---|---|---|
| Gerard et al. ( | Intraoperative guidance | 8 patients | To evaluate the feasibility of combining intraoperative ultrasound and AR in tumor surgery | Meningioma × 2, glioma × 4, metastases × 2 | IBIS (Drouin and Kochanowska, Montreal, Canada) | Not reported |
| Finger et al. ( | Neuroendoscopy and presurgical planning of biopsy and other procedures | 28 total patients with 14 having the underlying oncologic disease | To evaluate AR-enhanced navigated neuroendoscopy system for intraventricular pathologies | Various periventricular tumors | Nova Plan 2.6.10 (Scopis, Berlin, Germany) | Not reported |
| Chen et al. ( | Presurgical planning | 16 patients | To assess an AR system using mobile devices for presurgical planning of supratentorial lesions | Parietal, temporal, and frontal lesions (meningioma × 15, glioma × 1) | 3D Slicer 4.0 (Surgical Planning Laboratory, Brigham and Women’s Hospital, Boston, Massachusetts, USA) | Not reported |
| Sun et al. ( | Presurgical planning and intraoperative guidance | 79 patients with functional neuron avigation and intraoperative MRI and 55 control patients | To investigate the utility of combined VR and AR for intraoperative MRI and neuron avigation in glioma surgery | Glioma | iPlan 2.6 (BrainLab AG, Munich, Germany) SARL, Bernex, Switzerland) | 69.6% of the study group achieved complete resection, with an average extent of 95.2% compared with 36.4% and 84.9% in the study group; language, motor, and vision preservation were significantly higher in the study group |
| Watanabe et al. ( | Intraoperative guidance | 6 patients | To assess AR-based navigation system with whole operating room tracking | Various tumors | Amira (FEI, Hillsboro, Oregon, USA) | Not reported |
| Neuroendoscopy and presurgical planning | 22 patients | To evaluate the role and accuracy of virtual endoscopy for presurgical assessment | Pituitary adenomas | OsiriX (Pixmeo | Not reported | |
| Tabrizi and Mahvash ( | Intraoperative guidance | 5 patients | To intraoperatively evaluate a novel AR neuron avigation system | 3 metastases, 2 glioblastoma | MRIcro (Chris Rorden, Columbia, South Carolina, USA) | All tumors were successfully removed with no complications |
| Inoue et al. ( | Presurgical planning | 99 patients | To assess the utility of a 3D CT model for obtaining preoperative information regarding sphenoidal sinus procedures | Pituitary adenomas | 3D Advantage Workstation Volume Share 4 (GE Healthcare, Wauwatosa, Wisconsin, USA) | Not reported |
| Inoue et al. ( | Intraoperative guidance | 3 patients | To assess novel AR neuron avigation system using web cameras | Glioblastoma × 2, meningiomas × 2 | 3D Slicer | No new neurologic deficits occurred; 2 of 3 tumors were successfully removed in their entirety |
| Stadie and Kockro ( | Presurgical planning | 208 patients (Dextroscope) and 33 patients (Setred) | To report experiences with 2 different VR systems | Various tumors | Dextroscope (Volume Interactions Pte. Ltd., Singapore, Singapore) and Setred system (Setred, Stockholm, Sweden) | Not reported |
| Wang et al. ( | Presurgical planning | 60 patients | To examine the utility of VR in planning sellar region tumor resections | Various tumors in the sellar region | Dextroscope | Of the selected group of 30 participants, hormone levels and vision were improved; complications including CSF leakage and diabetes insipidus were noted in 5 patients |
| Stadie et al. ( | Craniotomy placement | 48 patients | To describe the method of defining the placement of the craniotomy for minimally invasive procedures | Various tumors | Dextroscope | Not reported |
| Low et al. ( | Presurgical planning | 5 patients | To assess the utility of AR surgical navigation for resection of meningiomas | Parasagittal, falcine and convexity meningiomas | Dextroscope | 4 of 5 patients had complete resection; 1 patient had neartotal excision; all patients had good neurologic recovery |
| Qiu et al. ( | Presurgical planning | 45 patients | To assess the utility of VR presurgical planning using DTI tractography for cerebral gliomas with pyramidal tract involvement | Cerebral gliomas involving pyramidal tracts | Dextroscope | Gross tumor resection in 33 of 45 (73%) patients and subtotal resection in 6 (13%) patients; 7 of 45 (16%) patients had improved motor function, and 30 of 45 (67%) patients had no change |
| Ferroli et al. ( | Presurgical planning | 64 patients | To assess clinical experience using stereoscopic virtual reality for surgical planning | Various tumors | Dextroscope | Not reported |
| Yang et al. ( | Presurgical planning | 42 patients in VR group and in the control group | To evaluate the outcome of presurgical planning using Dextroscope in patients with skull base tumors | Meningioma × 15, schwannoma × 15, other × 12 | Dextroscope | Total resection rate was 83% in VR group compared with 71% in the control group; complication rate, length of postoperative stay, and surgery duration were significantly reduced in VR group |
| Stadie et al. ( | Presurgical planning | 106 total cases, including 100 cranial lesions | To report on experiences with 3D virtual reality systems for minimally invasive surgical planning | Various tumors | Dextroscope | Not reported |
| Anil et al. ( | Presurgical planning | 1 patient | To report preoperative planning with Dextroscope for fourth ventricular ependymoma | Fourth ventricular ependymoma | Dextroscope | Tumor was entirely removed with patient having no immediate postoperative neurologic deficits |
| Rosahl et al. ( | Presurgical planning | 110 patients | To investigate the usefulness of VR in image guidance for skull base procedures | Various tumors | Image Guidance Laboratories (Stanford University, Stanford, California, USA | Not reported |
Studies on the treatment of post-traumatic stress disorder (PTSD) using virtual reality
| Authors | Study type | Number participants | Technical applied | Results |
|---|---|---|---|---|
| Difede and Hoffman ( | Case study | 1 | VRET | 90% reduction in symptoms of PTSD, 83% reduction in symptoms of depression |
| Beck et al. ( | Case study | 6 | VRET, relaxation techniques, in vivo exposure and in imago exposure | Reduction of symptoms of PTSD. No significant reduction in symptoms was found anxiety and depression |
| Rothbaum et al. ( | Case study | 1 | VRET | 45% reduction in symptoms of PTSD-retention beyond 6 months |
| McLay et al. ( | Controlled randomized trial | 20 | Group A: VRET, cognitive restructuring. Group B: pharmacotherapy and group therapy | 70% of those who underwent VRET showed > 30% improvement of PTSD symptoms compared to 12.5% of group B |
Studies on the treatment of panic disorder using virtual reality
| Authors | Study type | Number of participants | Techniques applied | Results |
|---|---|---|---|---|
| North et al. ( | Controlled study | 60 | Group A: VRET. Group B: none no treatment | Significant reduction in PTSD symptoms of the group receiving VRET-Control group showed no improvement |
| Jang et al. ( | Open, uncontrolled study | 7 | VRET | The effectiveness of VRET was not supported VR |
| Vincelli et al. ( | Controlled randomized study | 12 | Group A: BHT. Group B: GCCS. Group C: List Waiting list | Similar reduction in panic attack, anxiety, depression symptoms in both treatments. 33% Fewer sessions in the BHT. The superiority of both over the waiting list |
| Choi et al. ( | Controlled randomized study | 40 | Group A: BHT, Group B: GCCS | Significant reduction in seizure symptoms panic attacks in both treatments |
| Botella et al. ( | Controlled randomized study | 37 | Group A: VRET, Group B: In vivo report, Group C: List waiting list | Same reduction in panic attack symptoms and superiority over both treatments the waiting list. ∆Maintenance of treatment gains 12 months later |
Studies on the treatment of fear of flying using virtual reality
| Authors | Study type | Number of participants | Techniques applied | Results |
|---|---|---|---|---|
| Rothbaum et al. ( | Controlled randomized study | 45 | Group A: VRET, Group B: VRET, Group C: Waiting list | VRET and GCS were superior to the list waiting list. Between them, there was no significant difference. There was no significant difference between the treatment options. Gains were maintained 6 months after |
| Rothbaum et al. (repeat of the above study) (Rothbaum et al. | Controlled randomized study | 83 | Group A: VRET, Group B: GCS, Group C: Waiting list | 75 completed treatment. Confirmation of the results of the previous study. The therapeutic benefits were maintained at 6 and 12 months after |
| Wiederhold et al. ( | Controlled randomized study | 30 | Group A: VRET with feedback of physical stimuli, Group B: VRET without VRET feedback of the without somatic stimuli, Group C: In imago exposure | VRET with feedback: 100% effectiveness V RET without feedback: 80% effectiveness Both 2 were superior to In imago exposure (20% |
| Mühlberger et al. ( | Controlled randomized study | 45 | Group A: TBI with VRET (flight simulation), Group B: TF with VRET without motion, Group C: TTH | Reduction of symptoms was observed only in VRET with or without motion. Therapeutic benefits were maintained 6 months after |
| Krijn et al. ( | Controlled randomized study | 83 | Group A: VR Report, Group B: GCCS, Group C: Bibliotherapy without communication with the therapist All groups: After After treatment: after treatment, they received an additional 2 days of CrCB | 59 completed treatment. THE VRET and GCS were superior to bibliotherapy GCS after CrCB showed the greatest efficacy |
Studies on the Treatment of Social Phobia using Virtual Reality
| Authors | Study type | Number of participants | Techniques applied | Results |
|---|---|---|---|---|
| North et al. ( | Controlled study | 16 | Group A: VRET public speech, Group B: VRET speech in neutral audience | 14 people completed the treatment. Significant improvement of symptoms only group A hostile audience |
| Pertaub et al. ( | Pilot study | 10 | Group A: VRET on neutral emotionally neutral audience, Group B: VRET in a hostile/ hostile audience friendly audience | Stressful reactions were primarily elicited by the |
| Harris et al. ( | Controlled randomized trial | 14 | Group A: VRET, Group B: Waiting list | The superiority of VRET over waiting list |
| Roy et al. ( | Clinical trial (within groups design) | 10 | VRET in 4 conditions: performance, control, familiarity, and confidence | Improvement of symptoms |
| Klinger et al. ( | Clinical trial | 10 | VRET in 4 conditions: performance, control, intimacy and confidence | Improvement of symptoms |
| Klinger et al. ( | Controlled trial | 36 | Group A: VRET, Group B: GCS | Significant improvement of symptoms in both treatments |
Studies on the treatment of claustrophobia using virtual reality
| Authors | Study type | Number of participants | Techniques applied | Results |
|---|---|---|---|---|
| Botella et al. ( | Study case study | 1 | VRET | Reduction of symptoms-maintenance of therapeutic gains 1 month after |
| Botella et al. ( | Study case study | 1 of treatment gains 3 months after | VRET | Significant reduction in symptoms of claustrophobia. Reduction of agoraphobia and phobia symptoms storm fears without specific treatment for these phobias. ∆Maintenance |
| Botell et al. ( | Controlled study | 4 | VRET | Significant reduction in symptoms of fear and avoidance. ∆Maintenance of therapeutic gains 3 months after |
Applications of VR and AR in infectious diseases/pandemic
| Emergency management | Infection type | Technology application |
|---|---|---|
| Response (Javaid et al. | COVID-19 | Video calls (potential applications) |
| Preparedness (Real et al. | Influenza | Improving communication skills of residents under influenza vaccine hesitancy conditions |
| Preparedness (Nowak et al. | Influenza | Increasing beliefs and perceptions of individuals about the role of vaccination against transmission of the virus |
| Response (Zhou et al. | SARS | Controlling the spread of the outbreak by simulating human behaviors and interactions |
| Preparedness and response ( | SARS | Teaching methods for controlling transmission |
| Preparedness ( | Infections and microorganisms | Prevention of the transmission of the infection by teaching hand hygiene |
| Preparedness ( | Emergency pandemic (flu to bioterrorism) | Teaching public health preparedness exercises |
| Preparedness (Klomp et al. | Ebola and others | Preparation against disease-related disasters by training for improving safety, collaboration, and management |
| Preparedness (Ragazzoni et al. | H1N1 and others | Realizing training objectives at universities under quarantine |
| Preparedness (Bidaki and Ehteshampour | Respiratory system pathogenic agents | Providing a tool for learning about infectious diseases |
| Preparedness ( | Dengue virus | Education and epidemiological surveillance |
| Response (Rosenbaum et al. | Avian influenza | Realizing prevention and training objectives by providing location information and transmission patterns |